UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.

Stein, K; Rosenberg, W; Wong, J; (2002) Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut , 50 (2) pp. 253-258.

Full text not available from this repository.

Abstract

To estimate the cost utility of treatment with combination therapy (ribavirin and interferon alpha) for hepatitis C compared with no treatment or monotherapy (interferon alpha) based on UK costs and clinical management.

Type: Article
Title: Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.
Location: England
Keywords: Adult, Aged, Antiviral Agents, Cohort Studies, Cost-Benefit Analysis, Decision Support Techniques, Drug Combinations, Female, Health Resources, Health Status, Hepatitis C, Chronic, Humans, Interferon-alpha, Liver Transplantation, Male, Markov Chains, Middle Aged, Quality-Adjusted Life Years, Ribavirin, Sensitivity and Specificity
UCL classification: UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)
URI: http://discovery.ucl.ac.uk/id/eprint/1340663
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item